Navigation Links
Photoselective film proves effective for controlling height in potted gardenia plants
Date:5/4/2009

MAGNESIA, GREECETo grow the high-quality potted plants preferred by consumers, many growers use chemical "regulators" designed to affect plant growth and development. The use of chemical growth retardants is standard practice in the production of compact gardenia plants; the chemicals are used to reduce plants' internode length, and encourage the production of lateral shoots that create aesthetically pleasing, spherical plants with plentiful flower buds. Chemical sprays are effective at reducing gardenia plant height, but need to be applied regularlya practice that increases the cost of production and contributes to environmental pollution.

Dr. Constantinos Kittas and his colleagues from the University of Thessaly School of Agricultural Sciences and the Agricultural University of Athens (Greece) published a study in HortScience in which they report on experiments with the use of a photoselective polyethylene greenhouse covering filma less expensive and more environmentally friendly alternative to chemical treatmentfor production of compact potted gardenia (Gardenia jasminoides Ellis) plants.

Two types of experiments were performed on gardenia cuttings rooted in rooting benches and on young potted plants grown under low tunnels. In both experiments, two types of cover materials were used: a photoselective polyethylene (P-PE), filtering light within the wavelength range 600 to 750 nm and a common polyethylene film (C-PE) routinely used in greenhouse practice. The experiments were carried out in a commercial plastic-covered greenhouse located on the coastal area of eastern Greece.

The researchers recorded photosynthetically active radiation, cover materials' spectral properties, air temperature, and relative humidity inside the rooting benches and under the low tunnels. Plant growth indicators (including main shoot length and leaf area and lateral shoot number, leaf area, and fresh and dry weight) were determined along the
'/>"/>

Contact: Michael W. Neff
mwneff@ashs.org
703-836-4606
American Society for Horticultural Science
Source:Eurekalert

Page: 1 2

Related biology news :

1. Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study
2. Queens University Belfast improves Malaysian public health
3. Study finds rescue course of antenatal steroids improves outcome in premature babies
4. Organic plant waste proves effective weed control for citrus trees
5. An essay proves that vegetation could recover in the ski resort of Sierra Nevada
6. Replacing corn with perennial grasses improves carbon footprint of biofuels
7. Microarray analysis improves prenatal diagnosis
8. First at-home test for vasectomized men proves to be safe, accurate
9. Junk DNA proves functional
10. For insulin sensitive overweight patients, 1 session of exercise improves metabolic health
11. Coating improves electrical stimulation therapy used for Parkinsons, depression, chronic pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... developed by researchers at the NIH,s National ... its collaborators to treat sickle cell disease ... business. The drug candidate, Aes-103, is the ... molecular mechanism of sickle cell disease. Baxter ... required for regulatory approval and commercialization. , ...
(Date:7/9/2014)... receptor antagonists can alleviate the symptoms of ... cognitive dysfunction and effectively scavenge amyloid beta ... (Aβ) vaccines reduced and eliminated Aβ deposition ... model, and significantly improved behavioral and cognitive ... First Affiliated Hospital of China Medical University, ...
(Date:7/9/2014)... inhabitants of the sea: tiny haptophytes of the type ... eye, when they are in bloom in spring, they ... on satellite images. "Together with other phytoplankton, Emiliania ... global photosynthesis output," states Prof. Dr. Georg Pohnert of ... the greenhouse gas carbon dioxide CO2 is ...
Breaking Biology News(10 mins):First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4Short circuit in the food web 2
... tropical parasitic disease that can lead to life-threatening heart ... than previously thought, according to research from The University ... for four years now, and this year the number ... professor of integrative biology and philosophy at The University ...
... Cincinnati, OH, October 6, 2011 -- Directly advertising food ... providers, and the American Academy of Pediatrics and the ... impact of advertising on children,s healthy food choices. ... Journal of Pediatrics explores the relationship between ...
... can ever know about long-gone creatures is what they ... resurrect actual specimens and compare their features with their ... Toronto biologists helping to create a seed bank that ... allowing them to measure evolution caused by global change. ...
Cached Biology News:Chagas disease may be a threat in South Texas, says researcher 2Study suggests children's food choices are affected by direct advertising and parental influence 2Seed time-capsule will aid study of plant evolution amid environmental change 2
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... 14, 2014 iLab Solutions, the leader in ... new Director of Product Strategy. In this role, Michelle will ... sub-teams to guide in the development of iLab products. Her ... maximum possible benefit to the scientific community by offering the ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Calif., July 22 CV Therapeutics,Inc. (Nasdaq: CVTX ... results for 2008 after the market closes on Thursday, ... at 5:00 p.m. EDT,2:00 p.m. PDT, on the company,s ... on to the Company,s website at, http://www.cvt.com and ...
... is bringing aboard Ashton S. Maaraba, a key Pharmacy, Pharmacy Services ... , ... (PRWEB) July 22, 2008 -- PharmaSmart International ... Ashton S. Maaraba, a key Pharmacy, Pharmacy Services & HBC industry ...
... U.S. Department of Energy,s Lawrence Berkeley National Laboratory (Berkeley ... performed the first scanning tunneling spectroscopy of graphene flakes ... latest in a series of surprising insights into the ... carbon: an unexpected gap-like feature in the energy spectrum ...
Cached Biology Technology:CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008 2Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing 2A phonon floodgate in monolayer carbon 2A phonon floodgate in monolayer carbon 3A phonon floodgate in monolayer carbon 4A phonon floodgate in monolayer carbon 5